Finance

Lists
ERIS:NSE
Eris Lifesciences Ltd
₹1,276.10
+1.15%
(+14.50) 1D
Nov 11, 2:19:57 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ERIS...
Open
₹1,277.30
High
₹1,281.50
Low
₹1,246.10
Mkt. cap
177.04B
Avg. vol.
142.78K
Volume
39.23K
Dividend
0.57%
Quarterly dividend
₹1.80
Ex-dividend date
Feb 13, 2025
P/E ratio
24.93
52-wk high
₹1,740.00
52-wk low
₹1,069.00
EPS
₹51.19
Shares outstanding
137.52M
No. of employees
3K
Open
₹1,277.30
High
₹1,281.50
Low
₹1,246.10
Mkt. cap
177.04B
Avg. vol.
142.78K
Volume
39.23K
Dividend
0.57%
Quarterly dividend
₹1.80
Ex-dividend date
Feb 13, 2025
P/E ratio
24.93
52-wk high
₹1,740.00
52-wk low
₹1,069.00
EPS
₹51.19
Shares outstanding
137.52M
No. of employees
3K
News stories
From web sources and news partners
About Eris Lifesciences Ltd
CEO-
Employees2.76K
Founded2007
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteeris.co.in
Last report
Oct 26, 2026
Fiscal period
Q2 2027
₹15.84 / ₹13.55
+16.88%beat
Revenue / Est. (INR)
8.90B / 8.91B
-0.22%miss
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
8.01B
7.52B
8.69B
8.90B
Cost of goods sold
2.23B
2.10B
2.39B
2.26B
Cost of revenue
2.23B
2.10B
2.39B
2.26B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.38B
1.52B
1.53B
1.49B
Operating expense
3.66B
3.38B
4.06B
4.28B
Total operating expenses
5.90B
5.48B
6.45B
6.54B
Operating income
2.11B
2.04B
2.24B
2.36B
Other non operating income
200.00K
-19.40M
23.90M
32.00M
EBT including unusual items
1.45B
1.59B
1.79B
1.56B
EBT excluding unusual items
1.63B
1.59B
1.79B
1.92B
Income tax expense
365.20M
-1.20B
361.70M
-312.30M
Effective tax rate
25.13%
-75.08%
20.15%
-20.03%
Other operating expenses
1.58B
1.16B
1.80B
2.05B
Net income
997.20M
2.82B
1.42B
1.84B
Net profit margin
12.45%
37.44%
16.38%
20.67%
Earnings per share
8.26
20.57
10.26
15.84
Interest and investment income
-
34.70M
-
-
Interest expense
-488.20M
-456.00M
-466.50M
-464.20M
Net interest expenses
-488.20M
-421.30M
-466.50M
-464.20M
Depreciation and amortization charges
703.40M
695.70M
720.70M
734.20M
EBITDA
2.87B
2.70B
2.94B
3.09B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps